Charlestown, MA, United States of America

Phillip R Olivieri

This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillip R Olivieri. Retrieved from https://idiyas.com/inventor/phillip-r-olivieri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Phillip R. Olivieri

Introduction

Phillip R. Olivieri is a notable inventor based in Charlestown, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that modulate protein kinase activities. His work has implications for treating various diseases, including cancer and inflammation.

Latest Patents

Olivieri holds a patent for "Protein kinase modulators and method of use." This invention relates to chemical compounds that can modulate various protein kinase receptor enzymes. These compounds are designed to influence disease states related to the activities of these kinases, particularly in the process of angiogenesis and other proliferative disorders.

Career Highlights

Olivieri is associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions in the realm of protein kinase modulation. His research has the potential to lead to new therapeutic approaches for serious health conditions.

Collaborations

Olivieri has collaborated with notable colleagues, including Stephanie Geuns-Meyer and Brian Lewis Hodous. These collaborations have contributed to the advancement of research in the field of protein kinases and their therapeutic applications.

Conclusion

Phillip R. Olivieri's contributions to the field of biochemistry through his patent on protein kinase modulators highlight his innovative spirit and dedication to improving health outcomes. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…